Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - GFR PHARMACEUTICALS INC | Financial_Report.xls |
| EX-21.1 - SUBSIDIARIES - GFR PHARMACEUTICALS INC | ex21-1.htm |
| EX-31.1 - CERTIFICATION CEO - GFR PHARMACEUTICALS INC | ex31-1.htm |
| EX-31.2 - CERTIFICATION CFO - GFR PHARMACEUTICALS INC | ex31-2.htm |
| EX-32.2 - CERTIFICATION CFO - GFR PHARMACEUTICALS INC | ex32-2.htm |
| 10-K - CURRENT REPORT - GFR PHARMACEUTICALS INC | gfr_10k-123111.htm |
Exhibit 32.1
Certification Pursuant to
18 U.S.C. Section 1350
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of GFR Pharmaceuticals, Inc. (the “Company”) on Form 10-k for the year ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zhao Yan Ding, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge:
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: March 23, 2012
GFR PHARMACEUTICALS, INC.
|
/s/ Zhao Yan Ding
|
|
|
Zhao Yan Ding, Chief Executive Officer
|